Next Article in Journal
Mesoporous Silica Materials as Drug Delivery: “The Nightmare” of Bacterial Infection
Previous Article in Journal
Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessReview

In Vitro Immune Organs-on-Chip for Drug Development: A Review

1
Department of Biomedical Engineering, Khalifa University of Science and Technology, Abu Dhabi, P.O. Box 127788, UAE
2
Division of Engineering, New York University Abu Dhabi, Abu Dhabi, P.O. Box 129188, UAE
3
Department of Mechanical and Aerospace Engineering, New York University, New York City, P.O. Box 903, NY 10276-0903, USA
4
Healthcare Engineering Innovation Center, Khalifa University of Science and Technology, Abu Dhabi, P.O. Box 127788, UAE
*
Author to whom correspondence should be addressed.
Pharmaceutics 2018, 10(4), 278; https://doi.org/10.3390/pharmaceutics10040278
Received: 13 October 2018 / Revised: 12 November 2018 / Accepted: 21 November 2018 / Published: 15 December 2018
  |  
PDF [2024 KB, uploaded 15 December 2018]
  |  

Abstract

The current drug development practice lacks reliable and sensitive techniques to evaluate the immunotoxicity of drug candidates, i.e., their effect on the human immune system. This, in part, has resulted in a high attrition rate for novel drugs candidates. Organ-on-chip devices have emerged as key tools that permit the study of human physiology in controlled in vivo simulating environments. Furthermore, there has been a growing interest in developing the so called “body-on-chip” devices to better predict the systemic effects of drug candidates. This review describes existing biomimetic immune organs-on-chip, highlights their physiological relevance to drug development and discovery and emphasizes the need for developing comprehensive immune system-on-chip models. Such immune models can enhance the performance of novel drug candidates during clinical trials and contribute to reducing the high attrition rate as well as the high cost associated with drug development. View Full-Text
Keywords: drug development; drug discovery; immune system; in vitro; organ-on-chip; biomimicry drug development; drug discovery; immune system; in vitro; organ-on-chip; biomimicry
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Shanti, A.; Teo, J.; Stefanini, C. In Vitro Immune Organs-on-Chip for Drug Development: A Review. Pharmaceutics 2018, 10, 278.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top